Faes Farma, S.A. (LON:0K9H)

Market Cap	1.21B
Revenue (ttm)	466.12M
Net Income (ttm)	90.30M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	13.37
Forward PE	16.76
Dividend	0.12 (2.81%)
Ex-Dividend Date	Jul 3, 2025

Volume	3,461
Average Volume	4,312
Open	4.495
Previous Close	4.408
Day's Range	4.455 - 4.500
52-Week Range	3.270 - 4.735
Beta	0.36
RSI	62.39
Earnings Date	Oct 27, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 1,775
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0K9H

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial numbers in EUR